We tested serial serum samples for hepatitis C virus RNA from patients undergoing treatment for chronic hepatitis C with interferon-a using an assay that combined reverse transcription and polymerase chain reaction. The subjects studied were 20 patients with chronic hepatitis who had serum antibody
Serum levels of hepatitis C virus RNA in patients with chronichepatitis C treated with interferon alpha-2b and thymostimulin
β Scribed by M.C. Ribeiro; L.R. Singer; S. Raskin; J.E. Telles; E. Martins; C.A. Camargo Jr
- Book ID
- 119526382
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 121 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We quantified serum hepatitis C virus RNA titers and determined hepatltis C virus subtypes in chronic hepatitis C patients treated with interferon$ to investigate relationships among serum ALT response, serum hepatitis C virus titer and hepatitis C virus subtype. Of 146 chronic hepatitis C patients
The quantitation of hepatitis C virus (HCV) viremia RNA is measured by molecular techniques such as comcan be helpful in the diagnosis, therapy, and monitoring petitive reverse-transcription polymerase chain reacof patients with chronic hepatitis C. A sensitive and tion and branched DNA (bDNA) signa
## Abstract Hepatitis C virus (HCV), a positive stranded RNA virus, is the main causative agent of postβtransfusion and sporadic nonβA nonβB hepatitis worldwide. Paired samples of plasma and peripheral blood mononuclear cells (PBMC) from 11 patients with chronic hepatitis C treated with Ξ±βinterfero